• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Rare Diseases

    Immix Speeds Up NEXICART-2 Trial in AL Amyloidosis

    GLOBENEWSWIRE

    Immix EU Orphan Drug Tag for NXC-201 in Multiple Myeloma

    GLOBENEWSWIRE

    Immix Biopharma Awarded European Union Orphan Drug Designation for NXC-201

    GLOBENEWSWIRE

    FDA Approves Immix Biopharma Rare Pediatric Disease Designation for IMX-110

    PRESS RELEASE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.